Trending stocks: Ajanta Pharma shares rise 4.31%
The stock quoted a 52-week high of Rs 1536.5 and a 52-week low of Rs 825.

Ajanta Pharma got USFDA nod for Metformin Hydrochloride tablets.
The stock quoted a 52-week high of Rs 1536.5 and a 52-week low of Rs 825.
Financials
Ajanta Pharma, incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 12015.00 crore) operating in the Pharmaceuticals sector.
The company reported net profit after tax of Rs 107.55 crore for the quarter ended 31 December, 2019. For the same quarter, the company has reported Consolidated sales of Rs 651.21 crore, up 1.31 per cent from last quarter Sales of Rs 642.76 crore and up 34.24 per cent from last year same quarter Sales of Rs 485.11 crore.
Promoter holding
Promoters held 70.51077 per cent stake in the company as of quarter ended 31st Dec 2019.
Valuation ratio
It quoted a price-to-earnings ratio of 29.37 and price to book value of 5.59.
Download ET Markets APP